Welcome to our dedicated page for WORK Medical Technology Group SEC filings (Ticker: WOK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The WORK Medical Technology Group LTD (WOK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures as a foreign private issuer in the medical devices sector. WORK Medical files annual reports on Form 20-F and current reports on Form 6-K, detailing its operations in developing and manufacturing Class I and II medical devices and selling Class I and II disposable medical devices through subsidiaries in China.
In these filings, investors can review information on WORK Medical’s product portfolio of medical consumables and equipment, its sales footprint across 34 provincial-level administrative regions in China, and the registration of 17 products with the U.S. Food and Drug Administration. Form 6-K reports provide updates on interim financial statements and management’s discussion and analysis, extraordinary general meetings and voting results, changes in independent auditors, and capital markets transactions such as registered direct offerings, at-the-market sales agreements, and pre-funded warrants.
Filings also describe share structure changes and Nasdaq listing matters, including approved share consolidations (reverse stock splits), increases in authorized share capital, and correspondence with Nasdaq regarding minimum bid price compliance and potential delisting determinations. These documents outline the reasons for share consolidations, effective dates, and post-consolidation share counts, giving context to changes in the company’s capital structure.
On Stock Titan, users can access WORK Medical’s Forms 6-K and 20-F as they are furnished to the SEC’s EDGAR system, along with AI-powered summaries that highlight key points such as financing terms, governance changes, and listing status updates. The filings page is also a reference point for tracking any future registration statements, prospectus supplements, and other transactional documents that the company incorporates by reference into its shelf registration statements.
WORK Medical Technology Group LTD is offering Class A Ordinary Shares at $0.075 per share, with 56,999,442 Class A Ordinary Shares to be issued (and 95,998,776 shares assuming full exercise of Pre-Funded Warrants). The prospectus supplement states net proceeds will be used for working capital and general corporate purposes. The document highlights extensive risk factors tied to its PRC operations, including potential PRC government intervention, uncertainties in interpretation and enforcement of PRC laws, cybersecurity review rules, restrictions on using offshore proceeds to fund PRC subsidiaries, and the risk of delisting under the HFCA Act if PCAOB inspection is prevented. The company notes its dual-class share structure, potential dilution from future issuances and Pre-Funded Warrant exercise, and that it does not expect to pay dividends in the foreseeable future.
WORK Medical Technology Group LTD, a Cayman Islands company and foreign private issuer, filed a Form 6-K to furnish its unaudited consolidated financial statements and notes for the six months ended March 31, 2025. These financial statements are provided as Exhibit 99.1.
The company also furnished Management’s Discussion and Analysis of Financial Condition and Results of Operations for the same six-month period as Exhibit 99.2. Additional Inline XBRL data files and the cover page interactive data file are included among the technical exhibits.
WORK Medical Technology Group LTD filed a Form 6-K as a foreign private issuer to distribute materials for an upcoming extraordinary general meeting of shareholders. The company is furnishing the official notice and proxy statement for the meeting, along with a proxy card that shareholders can use to vote. These documents are provided as Exhibits 99.1 and 99.2 and will be mailed to shareholders. The filing is mainly procedural, ensuring investors receive the necessary information and voting forms for the meeting.